Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Amgen
Participants who were enrolled in study 20110118 (FOURIER; NCT01764633) at select sites in select countries (selected based on study start-up timelines) were invited to participate in this cognitive function study, 20130385. There was no separate randomization for Study 20130385; data were analyzed according to Study 20110118 randomized treatment arm.
Age
40–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Randomized into Study 20110118 (FOURIER; NCT01764633)
You may not be if
Current or known past diagnosis of dementia or mild cognitive impairment (MCI)
Clareo Health | Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
